- Home
- KOD vs MRBK Comparison
KOD vs MRBK Comparison
Compare KOD & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- MRBK
- Stock Information
- Founded
- KOD 2009
- MRBK 2004
- Country
- KOD United States
- MRBK United States
- Employees
- KOD N/A
- MRBK N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- MRBK Major Banks
- Sector
- KOD Health Care
- MRBK Finance
- Exchange
- KOD Nasdaq
- MRBK Nasdaq
- Market Cap
- KOD 198.4M
- MRBK 177.5M
- IPO Year
- KOD 2018
- MRBK 2017
- Fundamental
- Price
- KOD $9.35
- MRBK $15.52
- Analyst Decision
- KOD Hold
- MRBK Buy
- Analyst Count
- KOD 4
- MRBK 2
- Target Price
- KOD $11.75
- MRBK $17.50
- AVG Volume (30 Days)
- KOD 556.4K
- MRBK 64.6K
- Earning Date
- KOD 11-13-2025
- MRBK 10-23-2025
- Dividend Yield
- KOD N/A
- MRBK 3.22%
- EPS Growth
- KOD N/A
- MRBK 69.83
- EPS
- KOD N/A
- MRBK 1.61
- Revenue
- KOD N/A
- MRBK $106,330,000.00
- Revenue This Year
- KOD N/A
- MRBK $25.14
- Revenue Next Year
- KOD N/A
- MRBK $8.08
- P/E Ratio
- KOD N/A
- MRBK $9.66
- Revenue Growth
- KOD N/A
- MRBK 17.11
- 52 Week Low
- KOD $1.92
- MRBK $11.00
- 52 Week High
- KOD $11.60
- MRBK $17.33
- Technical
- Relative Strength Index (RSI)
- KOD 52.81
- MRBK 56.08
- Support Level
- KOD $8.91
- MRBK $15.13
- Resistance Level
- KOD $10.20
- MRBK $15.71
- Average True Range (ATR)
- KOD 0.75
- MRBK 0.22
- MACD
- KOD -0.12
- MRBK -0.07
- Stochastic Oscillator
- KOD 45.49
- MRBK 58.65
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.